First patient enrolled in Parkinson’s treatment study
A trial has begun in the US for the ENT-01 therapy treatment of Parkinson’s, with the first patient enrolled.
List view / Grid view
A trial has begun in the US for the ENT-01 therapy treatment of Parkinson’s, with the first patient enrolled.
A new study found that betaine supplementations given to mice reduced schizophrenic behaviours, indicating a drug target.
A new study has found an enzyme in the brains of mice models which induces Parkinson’s, suggesting future drug target.
Researchers have found a new drug target for Alzheimer’s disease after identifying a facilitating protein.
Researchers have grown identical brain organoids for the first time, opening avenues for neurological research.
Researchers find key molecule in depression and identify new therapeutic targets.
The findings offer clues that could one day lead to treatments for the neurological condition...
Scientists expect that it will soon be possible to treat brain diseases by restoring damaged areas in the brain by mass producing neurons using stem cells...
A simple blood test reliably detects signs of brain damage in people on the path to developing Alzheimer's disease...
New nuclear medicine tracers could help medical researchers find a cure for Alzheimer's and other neurodegenerative diseases.
SB Drug Discovery shows the validation of fluorescence and automated electrophysiology assays designed to assess agonists, antagonists and allosteric modulators of these receptors, culminating in a high-throughput electrophysiology assay suited to assessing multiple GABAA receptor subtypes on a single assay plate.
Caffeine plus another compound in coffee beans' waxy coating may protect against brain degeneration...
Restoring brain cell receptors helps restore normal behaviour...
Brain changes evident in scans before memory, cognitive decline...
Researchers have indicated that the accumulation of pathological tau triggers a safety valve mechanism in the otherwise well-regulated cell membranes...